LINC01700

Across TCGA pan-cancer cohorts, LINC01700 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01700’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where LINC01700 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01700 is over-expressed in tumor, although a few such as LUSC and LUAD show the opposite, repressed pattern.

LUSC, KIRC, and LUAD are the cancer types where LINC01700 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01700 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Female	All	−0.209	<.001	8	view →
KIRC	All	All	+0.105	<.001	7	view →
LUAD	All	All	−0.120	<.001	2	view →
KICH	All	All	−0.037	.003	2	view →
THCA	Male	II,III,IV	−0.020	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC01700–LUSC

Open the LUSC breakdown →